Clinical Study

Ast-008-102- A Phase 1B/2 Study Of Ast-008 Combined With Pembrolizumab In Patients With Advanced Solid Tumors

Posted Date: Jun 17, 2019

  • Investigator: Trisha Wise-Draper
  • Specialties: Cancer, Oncology
  • Type of Study: Drug

The goal of this study is to evaluate the safety and tolerability of AST-008 alone and in combination with pembrolizumab in adult patients with advanced solid tumors.


To Be Eligible: Must Be 18 Years Or Older, Have Inoperable Advances Solid Tumor, Nonpregnant And Breastfeeding, No Known History Of Hematologic Malignancy Or Active Infection


Cancer, Tumor

For More Information:

Uc Clinical Trial Office

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.